Germany: Corporate and Company Law

The Banking Directive Implementation and Bureaucracy Relief Act (Bankenrichtlinienumsetzungs- und Bürokratieentlastungsgesetz, BRUBEG), passed by the German Bundestag on 29 January 2026...

On 2 March 2026, the European Commission published a targeted consultation on private equity exits and the possible development of multilateral intermittent trading platforms for private company shares.

On 17 February 2026, the European Securities and Markets Authority (ESMA) imposed a total fine of EUR 1,374,000 on REGIS-TR S.A. for seven infringements under Regulation...

New approval and notification requirements for transactions in the German banking sector are expected to come into force on 1 April 2026 as a result of the BRUBEG...

The European chemical industry is facing a historic turning point: declining demand, cost disadvantages, and global overcapacity are forcing tough decisions—from plant closures to the restructuring of entire portfolios.

We are pleased to present our latest analysis on the public M&A market in Germany for 2025. This comprehensive report, prepared by A&O Shearman, provides an in-depth overview of the market developments and key trends that have shaped the landscape of public mergers and acquisitions in Germany over the past year, as well as an outlook for the German takeover market in 2026.

The chemical and pharmaceutical industry in Germany is undergoing a profound shift. Competitive pressure from Asia continues to intensify, regulatory demands are rising, and long-established innovation models are proving less effective under current market conditions.

Reducing unnecessary bureaucracy is an ongoing task for the German government. In the Coalition Agreement of the 20th legislative period, the governing parties agreed to reduce...

The EU Parliament has once again voted on the so-called Supply Chain Act and has opted for a significantly watered-down version. Nevertheless, supply chain compliance remains essential for companies.